This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Advances in Hypoxic Signaling: From Bench to Bedside
joint with Cancer and Metabolism
Organizer(s): Volker H. Haase, Cormac T. Taylor, Johanna Myllyharju and Paul T. Schumacker
Date: February 12 - 17, 2012
Location: Fairmont Banff Springs, Banff, AB, Canada
Supported by the Directors' Fund
Summary of Meeting:
Changes in tissue oxygen levels are frequently associated with pathological conditions such as pulmonary, cardiovascular and neoplastic diseases, but also occur physiologically during development. Recent advances in understanding the molecular basis of cellular and systemic hypoxia responses have led to the discovery of novel therapeutic targets that have the potential to impact the treatment of ischemic and neoplastic diseases. This Keystone Symposia meeting on Advances in Hypoxic Signaling: From Bench to Bedside will provide a state-of-the-art overview and critical discussion of hypoxia research and will serve as a superb platform for scientific exchange between senior and junior investigators, including students. This meeting brings together leading experts in the field of hypoxic signaling and will: 1) discuss the most recent advances in the regulation of cellular and systemic hypoxia responses; 2) examine the role of hypoxia response pathways in embryonic development, tumorigenesis, tissue injury and repair, inflammation and metabolism; and 3) highlight the latest developments in therapeutic targeting of hypoxia response pathways. This meeting aims to further our understanding of the biological response to hypoxia and promote use of this information for therapeutic gain. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Cancer and Metabolism, which will share a keynote address and a plenary session with this meeting.
Scholarship Deadline: October 13 2011
Discounted Abstract Deadline: October 13 2011
Abstract Deadline: November 14 2011
Discounted Registration Deadline: December 12 2011
We gratefully acknowledge additional support for this conference from:
Coy Laboratory Products Inc.HypOxygenInQ Biosciences CorporationRuskinn Technology Ltd, a division of the Baker Company, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genzyme Corporation
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL110500-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found